Newest Technologies for OverActive Bladder

by | May 6, 2024 | Bladder Control, Bladder Issues, Overactive Bladder, Urinary Incontinence

Ready for a Deep Dive into Technological Overactive Bladder Solutions? Let’s Get Started! 
Are you eager to find relief from those persistent overactive bladder symptoms? Get ready, because this week, we’re diving deep into some exciting treatment options that could change the game for you!
1. Sacral Neuromodulation (SNM): Get ready to explore the cutting-edge world of SNM! By targeting the sacral nerves, this innovative approach holds promise for improved bladder control and a renewed sense of freedom.  This is a short, one-time procedure with exceptionally easy maintenance that will let you step back into your life and take control. 
2. Peripheral Tibial Nerve Stimulation (PTNS) – ECOIN.  As its name suggests, this is a coin-sized implant near the ankle that sends electrical impulses to the tibial nerve. The design promises convenience, and, though it requires follow-up, has been shown to have decent results.
3. Peripheral Tibial Nerve Stimulation (PTNS) – BlueWind.  Similar to ECOIN, the BlueWind implant goes in near the ankle and gently stimulates the tibial nerve near your ankle. As with ECOIN, follow-up therapy is required. 
Stay tuned as we delve deeper into each of these treatments throughout the week! Let’s share experiences, ask questions, and support each other on the path to better bladder health. Together, we’ve got this! 

 

1. Pivotal Study of Leadless Tibial Nerve Stimulation with eCoin® for Urgency Urinary Incontinence: An Open-Label, Single Arm Trial

https://www.auajournals.org/doi/10.1097/JU.0000000000001733

The Journal of Urology. 2021

133 patients w/ OAB- 1-year

Ecoin: implantable tibial nerve stimulation device

 At 48 wks: 68% of patients experienced a 50% reduction in UUI episodes

16% of experienced device-related events.

 

 

2. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints

The-BlueWind-miniature-stimulator-vol03cm-D3mm-implanted-adjacent-to-the-posterior.png

BlueWind: https://pubmed.ncbi.nlm.nih.gov/28892221/

71% experienced clinical success at 6 months.

Clinical success defined as a ≥50% reduction in the number of leaks/day or number of voids/day or number of episodes with degree of urgency >2 or a return to <8 voids/day on a 3 Day diary. 

3-Year Followup of a New Implantable Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome 

Journal of Urology 2020. https://pubmed.ncbi.nlm.nih.gov/32271689/

 The overall treatment success rate was 75% at 36 months in the per protocol (16) and the intent to treat (20) analyses. In total, 73% of the patients reported improvement in health related quality of life scores above the minimal important difference of 10 points.

 

3. Axonics SNM

https://www.axonics.com/wp-content/uploads/2023/08/nau24615.pdf

Two‐year outcomes of the ARTISAN‐SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system

93% people had more than 50% reduction in UUI

75% reduction in UUI episodes across all study pts

Daily UUI episodes decreased by from 5.6 baseline to 1.0 at 2yrs 

80% of people at baseline had >8 UI/day (frequency). Avg of 11.6/day reduced to 8.6/day

Large Leaks 76 people at 2 years- 1.6 baseline to 0.1 at 2 years

Satisfaction 94%

 

images.jpg